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The human papillomavirus type 16 E1^E4 protein is expressed abundantly in cells supporting viral DNA amplification, but its expression is
lost during malignant progression. In cell culture, 16E1^E4 causes G2 cell cycle arrest by associating with and preventing the nuclear entry of
Cdk1/cyclin B1 complexes. Here, we show that 16E1^E4 is also able to associate with cyclin A and Cdk2 during the G2 phase of the cell cycle.
Only a weak association was apparent during S-phase, and progression through S-phase appeared unaffected. As with cyclin B1, the interaction of
16E1^E4 with cyclin A is dependent on residues T22/T23 and results in the accumulation of cyclin A in the cytoplasm where it colocalizes with
16E1^E4. 16E1^E4 serine 32 was found to be phosphorylated by Cdk2/cyclin A. We hypothesize that the interaction of 16E1^E4 with cyclin A
may serve to increase the efficiency with which 16E1^E4 is able to prevent mitotic entry.
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Papillomaviruses (PV) are small DNA viruses that show a
high degree of specificity in the species they infect (Lowy and
Howley, 2001). A further level of specificity is seen in the
varied tropisms PV have for different types of epithelial tissue.
Human papillomaviruses (HPV) are classed as being either low
risk, e.g., HPV 1 and 11, or high risk, e.g., HPV16. The former
are only associated with benign lesions (often called warts),
while the latter cause lesions that may become malignant. The
presence of HPV16 DNA is the major risk factor associated
with cervical cancer (Walboomers et al., 1999).
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the surface of the epithelium (Howley and Lowy, 2001). The PV
genome is normally maintained at low copy number in the basal
cells and in the lower layers of the epithelium. Differentiation of
the cells in the upper layers triggers a significant increase in
levels of viral DNA replication (viral DNA amplification), and
the new viral genomes are then packaged into infectious virions
(Lowy and Howley, 2001).
During these productive infections, the E1^E4 protein,
derived from a spliced transcript of the E1 and E4 open reading
frames (Doorbar et al., 1990), is found abundantly in the cyto-
plasm of cells in the upper layers of the epithelium (Doorbar et
al., 1997). Expression of 16E1^E4 results from activation of the
differentiation dependent promoter, and its expression is lost if
the lesion progresses towards malignancy (Middleton et al.,
2003). Viral DNA amplification is detected in cells that are
16E1^E4-positive (Crum et al., 1990; Doorbar et al., 1997), and
the current model suggests that genome amplification occurs in
cells that contain E1^E4 and S phase proteins such as PCNA,
MCM, and cyclin A. The dependency of amplification on the
presence of E1^E4 is supported by knock-out experiments in
HPV16, HPV31, and cotton tail rabbit PV (CRPV) in which
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genomes (Nakahara et al., 2005; Peh et al., 2004; Wilson et al.,
2005). The knock-out studies also showed that expression of the
viral capsid proteins is abrogated in the absence of E1^E4. It is
interesting to note that 16E1^E4 is able to bind at least one
factor involved in the regulation of protein expression, E4-DBP
(Doorbar et al., 2000). E1^E4 has also been implicated in the
release of new virus particles. 16E1^E4 has been shown in cell
culture (Doorbar et al., 1991) and in vivo (Wang et al., 2004) to
associate with keratin networks and cause them and their
attached 16E1^E4 to re-organize. It is thought that the decrease
in integrity of the keratin/16E1^E4 network may aid viral
egress. A similar role has been proposed for the 11E1^E4
protein which appears to disrupt the assembly of cornified
envelope (Bryan and Brown, 2000). Although PV are non-lytic
viruses and are shed from the surface of the epithelium as part of
the differentiation process of the tissue, 16E1^E4 has been
shown to bind to mitochondria, thus altering their membrane
potential and inducing apoptosis (Raj et al., 2004), although the
significance of this is not known.
Recently, it has become apparent that like many other PV
proteins, E1^E4 proteins can affect the cell cycle. Expression of
16E1^E4 in cell culture causes G2 arrest as a result of 16E1^E4
holding Cdk1/cyclin B1 in the cytoplasm (Davy et al., 2002,
2005; Nakahara et al., 2002). The G2 arrest phenotype appears
to be a property of E1^E4 proteins from other PV types
including HPV11 (Davy et al., 2002), HPV18 (Nakahara et al.,
2002), and HPV1 (Knight et al., 2004). For both 16E1^E4 and
18E1^E4, arrest appears to be mediated by a central region of
the protein (between amino acids 17 to 45 for 16E1^E4 and
between amino acids 21 to 59 for 18E1^E4). G2 arrest induced
by 16E1^E4 is inhibited by mutation of residues T22 and T23 to
alanines (Davy et al., 2002), and mutation of the corresponding
residue, T13, in the 1E1^E4 protein similarly abrogates arrest
(Knight et al., 2004). Despite the reliance of the type 1 and 16
E1^E4 proteins on similar residues, there appears to be some
disparity in their mechanisms of arrest. Unlike 16E1^E4 which
prevents nuclear entry of cyclin B1 (Davy et al., 2005), 1E1^E4
does not affect the subcellular localization of cyclin B1 but
instead decreases the number of cyclin B1-positive cells
(Knight et al., 2004).
Given that cell cycle progression is regulated by many
different Cdk and cyclin proteins, we were keen to determine
whether 16E1^E4 could affect other family members in addition
to Cdk1 and cyclin B1. In particular, the close correlation
between 16E1^E4 and viral DNA amplification suggested to us
that 16E1^E4 may have some impact on S phase proteins. In the
work presented here, we have further investigated the effect of
16E1^E4 on these key cell-cycle regulators. We find that as with
cyclin B1, 16E1^E4 associates with cyclin A2 (from here on
referred to as cyclin A) but does not appear to affect cyclins D or
E. Cyclin A is believed to have roles during S phase and at the
G2/M transition, but the interaction of 16E1^E4 with cyclin A
appears predominantly in cells that are in G2. As a result of
association, cyclin A becomes redistributed from the nucleus to
the cytoplasm, where it colocalizes with 16E1^E4. This can be
seen in cell culture and also in HPV16-induced lesions in thelayers within which viral DNA amplification is occurring.
Association with cyclin A is dependent on threonine residues
22/23 located within the proline-rich region of 16E1^E4, but the
residue that is phosphorylated by Cdk2/cyclin A is serine 32.
Results
Analysis of 16E1^E4 during the S and G2 cell cycle phases
As 16E1^E4 had already been found to bind and affect the
distribution of cyclin B1-containing complexes (Davy et al.,
2005), we investigated whether 16E1^E4 could affect other
cyclin complexes. Previous work investigating the interaction
of 16E1^E4 with cyclin B1 used cells that had been released
from a G1/S block for 16 h (Davy et al., 2005), in which cells
that express 16E1^E4 were found to have blocked in G2/M. In
the present work, to allow investigation of cyclins important for
earlier stages of the cell cycle, analysis was additionally carried
out at 4 h post-block release, i.e., when the cells are in S phase.
SiHa cells, a cell line derived from an HPV16-induced cervical
cancer, were synchronized at the G1/S boundary using serum
starvation followed by aphidicolin treatment and infected with
recombinant adenoviruses that expressed either β-gal or
16E1^E4. Cells were released from the block into medium
containing 10% FCS, and the cell cycle profile of the
populations was analyzed using propidium iodide staining and
flow cytometry. Fig. 1A shows that following our synchroni-
zation protocol, the majority of cells infected with β-gal- or
16E1^E4-expressing recombinant adenoviruses arrest with G1
DNA content (0 h). Fig. 1 also shows that at 4 h post-block
release, the cells that express β-gal and those that express
16E1^E4 are both in S phase. As expected, by 16 h post-block
release a difference in cell cycle profiles can be seen. This is in
agreement with previous work, which showed that cells that
express high levels of 16E1^E4 arrest in G2, while those that
express β-gal return to G1 (Davy et al., 2002, 2005).
16E1^E4 decreases the solubility of cyclin A and Cdk2 in a
cell-cycle-dependent manner but does not affect Cdk4, cyclin
D, or cyclin E
The association of 16E1^E4 with cyclin B1 and Cdk1 was
found to result in a reduction in solubility of these proteins
(Davy et al., 2005). To determine if 16E1^E4 has the ability to
reduce the solubility of other cyclin and Cdk proteins, detergent
fractionation was used (Fig. 1B). Cells expressing β-gal or
16E1^E4 were lysed in a buffer containing 0.5% NP-40 and
centrifuged to obtain the NP-40-soluble and -insoluble
fractions. As expected, the controls tubulin and GAPDH are
found exclusively in the NP-40-soluble fraction and at
equivalent levels in the β-gal and 16E1^E4 samples. Similarly
histone 2B is found almost exclusively in the NP-40-insoluble
fraction, again at equivalent levels in the β-gal and 16E1^E4
samples. At 16 h, it was found, as before, that cyclin B1 and
Cdk1 as well as being present in the NP-40-soluble fraction
were additionally present in the NP-40-insoluble fraction. This
was not the case for cyclin E, cyclin D, or Cdk4, which were all
Fig. 1. The effect of 16E1^E4 on cell cycle regulators in S phase and G2/M. G1/S synchronized SiHa cells infected with recombinant adenoviruses that express β-gal
or 16E1^E4 were harvested at 0, 4 and 16 h post-block release. (A) Cells were stained with immunofluorescent antibodies and with propidium iodide and were
analyzed by flow cytometry. Plots show cell number versus DNA content. (B) Cells were harvested at 16 h and 4 h post-block release. The cells were fractionated into
0.5% NP-40-soluble and -insoluble fractions. Fractions were Western blotted for 16E1^E4; cyclins A, B1, D, and E; Cdk1, Cdk2, and Cdk4; and (as controls for
fractionation), tubulin, GAPDH, and histone 2B. (C) Cells were harvested at 4 and 16 h post-block release. Cell extracts wereWestern blotted for cyclins A and B1, and
Cdks 1 and 2, using GAPDH and tubulin loading controls as appropriate.
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Cdk2 however were found to partially redistribute to the NP-40-
insoluble fraction, suggesting that as with Cdk1 and cyclin B1,
Cdk2 and cyclin A have the ability to interact with 16E1^E4 at
16 h, i.e., in G2. In contrast when the same fractionation was
carried out at 4 h, i.e., in S phase, Cdk1 and Cdk2 were not
desolubilized. To emphasize this point, the 4-h extracts are
shown at much greater exposure than the 16 h, and while
insoluble bands of Cdk1 and Cdk2 appear at 16 h, they are not
present at 4 h. In addition, the proportions of cyclins A and B
seen to be desolubilized were much smaller than at 16 h, andagain, the 4 h extract was exposed for longer to highlight this
difference. As at 16 h, no desolubilization of Cdk4 or cyclins D
or E was observed at 4 h. Interestingly, while at 16 h 16E1^E4
was observed both in the soluble and insoluble fractions, at 4 h,
the 16E1^E4 was completely insoluble.
16E1^E4 does not affect the levels of cyclin A or Cdk2
The interaction of 16E1^E4 with cyclin B1 did not result in a
change in the levels of cyclin B1 or Cdk1 (Davy et al., 2005). To
examine whether this was similarly the case for cyclin A and
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and compared to levels of control proteins on the same blot. Fig.
1C shows that as for Cdk1 and cyclin B1, there is no difference
in the levels of cyclin A or Cdk2 between β-gal- and 16E1^E4-
expressing cells at 4 and 16 h.
In G2, 16E1^E4 causes relocalization of cyclin A from the
nucleus to the cytoplasm where it associates with 16E1^E4
Analysis of cells expressing 16E1^E4 had shown that cyclin
B1 was relocalized from a diffuse cytoplasmic pattern to one in
which it colocalized with 16E1^E4 (Davy et al., 2005). Cyclin
A is a protein that normally displays both cytoplasmic and
nuclear staining patterns (Pines and Hunter, 1991). To
determine the effect of 16E1^E4 on the intracellular distribution
of cyclin A, immunofluorescence microscopy was carried out
on synchronized cells that express β-gal or 16E1^E4 harvested
at 16 h. As shown in Fig. 2A, while the distribution of β-gal in
cells is fairly uniform, 16E1^E4 appears with a number of
different distribution patterns, and the significance of these will
be considered in more detail in Figs. 4 and 5. Fig. 2A shows that
as expected, cells at 16 h that express 16E1^E4 show discrete
colocalization with cyclin B1 but not with the tubulin control.
Immunostaining of control cells that express β-gal shows cyclin
A predominantly in the nucleus, with some diffuse cytoplasmic
staining and no discrete colocalization between β-gal and cyclin
A. In contrast, in cells that express 16E1^E4, there appears little
cyclin A in the nucleus. Instead, the cyclin A in 16E1^E4-
expressing cells is often found associated with 16E1^E4 in the
cytoplasm. In fact a number of different staining patterns were
observed (see Fig. 2A). To quantify the proportions of cells
showing different staining patterns, every cell containing
16E1^E4 and cyclin A was scored according to the degree of
colocalization. It was found that only 1% of cells showed no
colocalization of cyclin A with 16E1^E4 (e.g., cell “1”, Fig.
2A). Of the 99% of cells that showed some colocalization, 19%
of cells showed less than 50% colocalization (e.g., cell “2”, Fig.
2A), and 80% of cells showed greater than 50% colocalization
(e.g., cell “3”, Fig. 2A). This was not significantly different
from observations of cyclin B1 colocalization with 16E1^E4;
3% showing no colocalization, 16% showing less than 50%
colocalization, and 81% showing greater than 50% colocaliza-
tion. Analysis of optical sections obtained using confocal
immunofluorescence microscopy suggested that despite most of
the cyclin A in these 16E^E4-expressing cells being found
colocalized with 16E1^E4 in the cytoplasm, some cyclin A does
remain in the nucleus (Fig. 2B).
Cells in S phase show little association of cyclin A with
16E1^E4
To assess whether association of cyclin Awith 16E1^E4 was
independent of cell cycle stage, immunofluorescence micros-
copy was carried out on cells that express β-gal or 16E1^E4
harvested at 4 h as they pass through S phase. In contrast to the
good colocalization observed at 16 h post-block release, at 4 h
cyclin A rarely appears to colocalize with 16E1^E4 (Fig. 3).The patterns were quantified as above, and now, the majority of
the cells (63%) showed no colocalization. Of the remaining
cells, most (34%) showed less than 50% colocalization, with
only a few (3.5%) showing a degree of colocalization greater
than 50%. Colocalization was not observed in control cells. The
decrease in colocalization seen in S phase compared to G2 is in
agreement with what was found regarding the solubility of
cyclin A (Fig. 1B). The solubility of cyclin A is reduced by
16E1^E4 at 16 h, but this effect is not so apparent at 4 h. Since
cyclin A does not colocalize well with 16E1^E4 during S phase,
it is perhaps not surprising that changes to its solubility are not
detected. Confocal immunofluorescent microscopy showed
again that in cells in which some of the cyclin Awas associated
with 16E1^E4 in the cytoplasm, a fraction of the cyclin A was
still free and found in the nucleus (Fig. 3B).
In addition to the lack of 16E1^E4 colocalization with
cyclin A, a difference was also noted between 4 h and 16 h
cells in the integrity of their 16E1^E4 networks. The trend is
illustrated in Fig. 3C, which shows that at 4 h, the majority
of cells have filamentous 16E1^E4, while at 16 h, the
majority of cells no longer show filaments as a result of
network re-organization.
Comparison of the colocalization of cyclin A with 16E1^E4
during S and G2 phases
To investigate the reasons why cyclin A might colocalize
with 16E1^E4 in G2 but not in S phase, we first compared the
levels of cyclin A, Cdk1, Cdk2, and 16E1^E4 in 16E1^E4-
expressing cells at 4 and 16 h by Western blot (Fig. 4A). While
levels of cyclin A, Cdk1, and Cdk2 are not significantly different
at 4 h compared to 16 h, there is a large increase in the expression
of 16E1^E4 between these time-points. This occurred even
though the cells had been infected with the rAd.16E1^E4 for the
same length of time. Analysis of the β-gal expression from the
control recombinant adenovirus showed only a modest increase
in levels at 16 h compared to 4 h. This suggests that the
differential expression of 16E1^E4 at different stages of the cell
cycle may be an inherent feature of the protein, a characteristic
that is apparent when other expression systems are used (data not
shown). To examine whether the lower levels of 16E1^E4 at 4 h
might explain the lack of cyclin A colocalization, cells were
selected from the 4-h population that showed abundant 16E1^E4
by immunofluorescent microscopy. These were compared with
cells from the 16-h population that appeared to express lower
levels of 16E1^E4, by equivalent exposure digital imaging
(using IP Lab imaging software). It can be seen from Fig. 4B that
the level of 16E1^E4 in the cell does not appear to correlate with
the ability to colocalize with cyclin A. This is apparent from cells
1 and 2 of the 4 h panels which show abundant 16E1^E4 yet lack
cyclin A colocalization while cells 5 and 6 in the 16-h panels
show low-level 16E1^E4 yet good colocalization with cyclin A.
Cell 4 in the 4-h panel and cell 8 in the 16-h panel show similar
levels and extent of collapse of 16E1^E4, yet there is better
cyclin A colocalization at 16 h than at 4 h.
As noted earlier, the cells at 4 and 16 h show differences in
the integrity of their 16E1^E4 networks. It was also noticed that
Fig. 2. 16E1^E4 association with cyclin A in G2. G1/S synchronized SiHa cells expressing β-gal or 16E1^E4 were fixed at 16 h post-block release. Cells were stained
for β-gal or 16E1^E4 (green) and cyclin B1, tubulin, or cyclin A (red). A DAPI nuclear stain was included in the merged image (blue). Scale bars equal 10 μm. Cells
were analyzed (A) using the 40× lens on a standard immunofluorescent microscope or (B) using confocal immunofluorescent microscopy. Cell “1” shows no
16E1^E4-cyclin A colocalization, cell “2” shows less than 50% colocalization, and cell “3” shows greater than 50% colocalization. (For interpretation of the references
to colour in this figure legend, the reader is referred to the web version of this article.)
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in which 16E1^E4 was completely filamentous, e.g., cell 3 in
the 4-h panel of Fig. 4B, cyclin A was rarely seen to colocalize
with 16E1^E4. Such purely filamentous cells are a commonfeature of the 4 h time-point but are not often found at 16 h.
Conversely, in cells in which 16E1^E4 existed as small
perinuclear bundles, e.g., cells 5 and 6 in Fig. 4B, cyclin A
was seen to colocalize well (such cells are typical of 16 h, not of
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dependency of the cyclin A interaction may be due to the degree
of network re-organization. To determine if this is the case, the
integrity of the 16E1^E4 network was compared with the extent
of cyclin A colocalization (Fig. 4C). Although it appears that the
greater the degree of network re-organization, the greater the
amount of colocalization, when cell populations with equivalent
degrees of re-organization were compared at 4 and 16 h,
statistically significant differences were found between their
levels of cyclin A colocalization (P ≤ 0.001, see Fig. 4). This
suggests that while the cell-cycle-related network re-organiza-
tion may be a factor contributing to cyclin A colocalization,
other factors that vary between S phase and G2 are also
important.
Oneway in which 16E1^E4 is potentially modified during the
cell cycle is by phosphorylation. This can be seen by SDS-PAGE,
where monomeric 16E1^E4 appears as two bands, the upper
band being more phosphorylated than the lower band (Wang et
al., 2004). Western blotting shows that the ratio of the two bands
is similar at the two time-points (Fig. 4A), suggesting that the
phosphorylation event that results in the migration change is
unlikely to be involved in the differential cyclin association A.
Cdk2 and Cdk1 colocalize with 16E1^E4 in a
cell-cycle-dependent manner
It had already been shown that Cdk1, like cyclin B1,
colocalizes with 16E1^E4 during G2 (Davy et al., 2005). To
determine if this was similarly the case for Cdk2, we used
immunofluorescence microscopy. As we had already ob-
served a difference in the desolubilization of Cdk2 by
16E1^E4 between S phase and G2, we used cells from both
stages. The proportions of cells showing no colocalization,
low-level colocalization, or high-level colocalization with
16E1^E4 were determined for Cdk2 and Cdk1 at 4 and 16 h
(Fig. 5A), and examples of different cell types are shown
(Fig. 5B). The data show that Cdk2, like Cdk1 colocalizes
with 16E1^E4. To examine whether as with cyclin A, the
degree of filament re-organization was not the sole determi-
nant of colocalization, the integrity of the 16E1^E4 network
was compared with the extent of Cdk colocalization. When
cell populations with equivalent degrees of re-organization
were compared at 4 and 16 h, statistically significant
differences were found between their levels of Cdk
colocalization (P ≤ 0.001, see Fig. 5). This supports the
data obtained for cyclin A (Fig. 4), which suggested that
some other cell-cycle-related factor, in addition to re-
organization of the filaments, controls the ability of
16E1^E4 to colocalize with these cell cycle proteins.
Cyclin A association is dependent on threonine residues within
the proline-rich region of 16E1^E4
It had previously been shown that residues T22 and T23
within the proline-rich region of 16E1^E4 are important for
binding cyclin B1 in vitro (Davy et al., 2005). To determine
if these residues were also important for binding cyclin A,cells transfected with plasmids that express β-gal, wild-type
16E1^E4 or 16E1^E4-T22A,T23A were immunostained. Fig.
6A shows that while the wild-type protein colocalizes with
cyclin A (as it does when expressed by adenovirus vectors),
the T22A,T23A mutation inhibits this interaction (Fig. 6B).
As expected, cyclin A does not colocalize with β-gal. The
reduction in binding ability of the T22A,T23A mutant was
also observed by GST pull-downs (Figs. 6C and D). Wild-
type 16E1^E4 and T22A,T23A-16E1^E4 GST fusions were
produced along with GST alone and coupled to glutathione
beads. Proteins eluted from different volumes of beads were
separated by SDS-PAGE and Coomassie stained to assess
the relative efficiencies of coupling (Fig. 6C). Equivalent
amounts of GST and GST fusion proteins on beads were
used in pull-downs of cell extracts, and the eluted proteins
were Western blotted for cyclin A (Fig. 6D). While GST-
wild-type 16E1^E4 is able to pull-down cyclin A, GST alone
cannot. The ability of GST-T22A,T23A-16E1^E4 to pull-
down cyclin A is reduced compared to wild type, and this
reduction in affinity may explain the lack of colocalization
between T22A,T23A-16E1^E4 and cyclin A in cells.
Together, these data suggest that interaction with cyclin B1
and cyclin A is dependent on the same site on 16E1^E4. As
yet it is not clear for either cyclin protein whether the
interaction is direct or indirect. Type 11 E1^E4 protein has
also been shown to be capable of inducing G2 cell cycle
arrest (Davy et al., 2002) and contains a region similar to
that found to be important for 16E1^E4-cyclin A binding. To
determine if 11E1^E4 can also associate with cyclin A, cells
transfected with a plasmid that expressed 11E1^E4 were
stained for cyclin A and 11E1^E4 (Fig. 6E). As with
16E1^E4, the 11E1^E4 protein is able to associate in cells
with cyclin A. This suggests that low risk and high risk
HPV types can have E1^E4 proteins that interact with
cyclins.
16E1^E4 Ser32 is a substrate for Cdk2/cyclin A
To determine whether 16E1^E4 is a substrate for phosphor-
ylation by Cdk2/cyclin A, bacterially expressed 16E1^E4 was
used in an in vitro kinase assay with Cdk2/cyclin A. Fig. 7A
shows that in the presence of 16E1^E4 and Cdk2/cyclin A,
phosphorylated bands of the correct size for 16E1^E4 and
multimers of 16E1^E4 appear. These bands are absent when
either the kinase complex or 16E1^E4 are omitted from the
reaction. This suggests that Cdk2/cyclin A can phosphorylate
16E1^E4 in vitro.
16E1^E4 contains a number of sites that match the consensus
for phosphorylation by Cdk2/cyclin A. To determine which
residue is phosphorylated by Cdk2/cyclin A, the phosphory-
lated 16E1^E4 protein was analyzed by mass spectrometry.
Nanospray mass spectrometry coupled with collision-induced
fragmentation (data not shown) suggested that the residue
phosphorylated was found within a fragment consisting of
residues 32 to 34. Contained within this region is a site
matching the Cdk2/cyclin A consensus site for phosphorylation,
i.e., S32P33 (Fig. 7B). To determine if serine 32 is the residue
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was tested in the in vitro kinase assay. Fig. 7C shows that
mutation of serine 32 to alanine abolishes the majority of
phosphorylation by Cdk2/cyclin A, suggesting that it is this
residue that is the primary target of the Cdk2/cyclin A kinase
complex.To determine if the S32 site was phosphorylated in cells,
extracts from cells that express wild-type and S32A-16E1^E4
proteins were analyzed by 2D electrophoresis; iso-electric
focusing in the first dimension and SDS-PAGE in the second
dimension. Fig. 7D top panel shows that in extracts from cells
that express wild-type 16E1^E4, two spots are apparent, and
Fig. 4. Comparison of 16E1^E4-cyclin A association at 4 h and 16 post-block release. G1/S synchronized SiHa cells simultaneously infected with recombinant
adenoviruses expressingβ-gal or 16E1^E4were harvested at 4 and 16 h post-block release. (A)Cell extracts separated on the same gelwereWestern blotted for 16E1^E4,
β-gal, cyclin A, Cdk1, and Cdk2 using GAPDH and tubulin as loading controls. (B) Cells were double stained for 16E1^E4 (green) and cyclin A (red). A DAPI nuclear
stain was included in the merged image (blue). Immunofluorescent images were captured using equal exposure times to allow comparison between 4-h and 16-h cells.
Scale bar equals 10 μm. (C) Immunofluorescent microscopywas used to analyze approximately 600 cells frommultiple experiments that were visually positive for both
16E1^E4and cyclinA.Cellswere categorized according to the extent of filament reorganization and the degree of cyclinAcolocalization. Pie charts show the proportions
of cells at 4 h and 16 h having particular degrees of 16E1^E4 reorganization and cyclin A colocalization. For all categories of 16E1^E4 pattern, a greater degree of
colocalization with cyclin A is observed at 16 h compared to 4 h. The χ2 test gave P values of≤0.001 for the “filamentous with partial reorganization” category and of
≤0.001, for the “partial reorganization, not filamentous” category. These χ2 values suggest that the null hypothesis, which states that for any given degree of re-
organization, there is no difference in ability of cyclinA to colocalizewith 16E1^E4at 4 h or 16h, shouldbe rejected.The number of 4 h cells showing “complete collapse”
and the number of 16h cells being “filamentous”were too small for statistical analysis to be appropriate. (For interpretation of the references to colour in this figure legend,
the reader is referred to the web version of this article.)
237C.E. Davy et al. / Virology 349 (2006) 230–244these correspond to 16E1^E4 modified by the addition of one
(approximately pI 8) and two (approximately pI 7) phosphates
(as predicted by Scansite, http://scansite.mit.edu). No com-
pletely unphosphorylated protein is present. In contrast, in
extracts from cells that express S32A-16E1^E4, the pI of the
two spots has been increased with one of the spots now
corresponding to singly phosphorylated 16E1^E4 and the other
(approximately pI 9), representing unphosphorylated 16E1^E4
(Fig. 7D, middle panel). This suggests that in wild-type
16E1^E4, the protein can be phosphorylated on two sites; theFig. 3. 16E1^E4 association with cyclin A in S phase. G1/S synchronized SiHa cell
stained for β-gal or 16E1^E4 (green) and cyclin B1, tubulin, or cyclin A (red). A DAP
were analyzed (A) using the 40× lens on a standard immunofluorescent microscope or
observed between 16E1^E4 and tubulin or β-gal and cyclin A. (C) Immunofluoresc
from multiple experiments harvested at 4 and 16 h. Cells were categorized as “filam
“filamentous with partial re-organization” if 16E1^E4 filaments were present bu
filamentous”, if no filaments were present and the reorganized 16E1^E4 had not ye
apparent was in small, smooth edged regions. (For interpretation of the references to ctwo spots correspond to 16E1^E4 that is phosphorylated on S32
only and 16E1^E4 that is phosphorylated on S32 and another
site. Mutation of serine 32 to alanine removes one of the
phosphorylation sites such that now the protein only has the
potential to be phosphorylated on one site, and some of the
protein remains unphosphorylated.
To investigate if the kinase in cells responsible for
phosphorylation of 16E1^E4 on serine 32 is Cdk2/cyclin A,
we treated cells expressing wild-type 16E1^E4 with the Cdk
inhibitor roscovitine and analyzed the phosphorylation status ofs expressing β-gal or 16E1^E4 were fixed at 4 h post-block release. Cells were
I nuclear stain was included in the merged image (blue). Bars equal 10 μm. Cells
(B) using confocal immunofluorescent microscopy. No discrete colocalization is
ent microscopy was used to analyze approximately 600 16E1^E4-positive cells
entous” if they contained 16E1^E4 filaments with no apparent re-organization;
t regions of re-organization could also be seen; “partial re-organization, not
t attained smooth edges; and finally “complete collapse” if the only 16E1^E4
olour in this figure legend, the reader is referred to the web version of this article.)
Fig. 5. Association of Cdk1 and Cdk2 with 16E1^E4. G1/S synchronized SiHa cells simultaneously infected with recombinant adenoviruses expressing β-gal or
16E1^E4 were harvested at 4 and 16 h post-block release. (A) Cells were double stained for β-gal or 16E1^E4 (green) and Cdk1 or Cdk2 (red). A DAPI nuclear stain
was included in the merged images (blue). Bar equals 20 μm. Immunofluorescent microscopy was used to analyze approximately 600 cells from multiple experiments
that were visually positive for 16E1^E4. (A) Cells were categorized according to their degree of Cdk colocalization with 16E1^E4. (B) Examples of typical staining
patterns. (C) Cells were categorized according to the degree of Cdk colocalization with 16E1^E4 and the extent of filament reorganization. Pie charts show the
proportions of cells at 4 h and 16 h having particular degrees of 16E1^E4 reorganization and Cdk colocalization. For all categories of 16E1^E4 pattern, a greater degree
of colocalization with Cdk is observed at 16 h compared to 4 h. The χ2 test gave P values of≤0.001 for the “filamentous with partial reorganization” (e.g., cells 2 and 6)
category and of ≤0.001, for the “partial reorganization, not filamentous” category (e.g., cells 3 and 7). These χ2 values suggest that the null hypothesis, which states
that for any given degree of reorganization, there is no difference in ability of Cdk to colocalize with 16E1^E4 at 4 h or 16 h, should be rejected. The number of cells
showing “complete collapse” (e.g., cells 4 and 8) and the number of cells being “filamentous” (e.g., cells 1 and 5) were too small for statistical analysis to be
appropriate. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
238 C.E. Davy et al. / Virology 349 (2006) 230–24416E1^E4 using 2D electrophoresis (Fig. 7D, bottom panel).
Roscovitine treatment results in loss of the doubly phosphor-
ylated form of 16E1^E4 which suggests that this drug is able to
inhibit a kinase that phosphorylates 16E1^E4 in cells.
As with all experiments of this type, these results do not
conclusively show that 16E1^E4 is phosphorylated in cells by
Cdk2/cyclin A because roscovitine can directly inhibit a number
of other kinase complexes and also indirectly inhibit other
kinases through downstream signaling pathways. However, the
combination of data derived from in vitro kinase assays, mass
spectrometry, 2D electrophoresis, mutational analysis, andinhibitor analysis provides strong support that 16E1^E4 serine
32 can be phosphorylated in cells by Cdk2/cyclin A.
Localization of cyclin A in 16E1^E4-expressing cells of
HPV16-induced lesions
In addition to observing cyclin B1 associating with 16E1^E4
in cultured cells, cyclin B1 was also seen to partially colocalize
with 16E1^E4 in HPV16-induced lesions and raft cultures
(Davy et al., 2005). To determine whether the association of
cyclin Awith 16E1^E4 is also found in vivo, lesions induced by
Fig. 6. Association of cyclin Awith mutant 16E1^E4. (A) Plasmids that express β-gal, wild-type 16E1^E4 or T22A,T23A 16E1^E4 proteins were transfected into cells
and were fixed at 48 h post-transfection. Cells were double stained for β-gal or 16E1^E4 (green) and cyclin A (red). A DAPI nuclear stain was included (blue) in the
16E1^E4 and merged images. Bar equals 20 μm. (B) Colocalization between β-gal or 16E1^E4 and cyclin A was quantified visually by immunofluorescent
microscopy. Cells that expressed β-gal or 16E1^E4 and cyclin Awere classified as having 0%, less than 50% or greater than 50% colocalization. Results shown are the
mean of three experiments, ±SEM. (C) GST, GST-wild-type-16E1^E4 and GST-T22A,T23A proteins were prepared from bacterial extracts and coupled to glutathione
beads. Proteins were eluted from varying volumes of the beads, separated by SDS-PAGE and stained using Coomassie. (D) GST beads (5 μl plus 45 μl of uncoupled
beads), GST wild-type 16E1^E4 beads and GST-T22A,T23A beads (50 μl each) were used in pull-down experiments, with and without cell extracts derived from
unsynchronized SiHa cells. The precipitated proteins wereWestern blotted for cyclin A and are shown compared to 50% of the input amount of cyclin A. (E) A plasmid
that expresses wild-type 11E1^E4 protein was transfected into cells and fixed at 48 h post-transfection. Cells were double stained for 11E1^E4 (green) and cyclin A
(red). A DAPI nuclear stain was included (blue). Bar equals 20 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
239C.E. Davy et al. / Virology 349 (2006) 230–244HPV16 were immunostained. It has previously been shown that
such lesions have regions of overlap between expression of
16E1^E4 and cell cycle proteins such as MCM, PCNA andcyclin A (Middleton et al., 2003). Such regions are the sites of
viral genome amplification which is seen to correlate with
16E1^E4 expression (Doorbar et al., 1997). Fig. 8A illustrates
Fig. 7. Phosphorylation of 16E1^E4 S32 by Cdk2/cyclin A. (A) Bacterially expressed and purified 16E1^E4 was used as a substrate in an in vitro kinase reaction with
Cdk2/cyclin A. The reaction was separated by SDS-PAGE and analyzed using a phosphorimager. (B) The amino acid sequence of wild-type 16E1^E4 showing the
location of the residues identified as critical for cyclin binding and the residue phosphorylated in vitro by Cdk2/cyclin A. (C) In vitro phosphorylation by Cdk2/cyclin
A of bacterially expressed wild-type and S32A-16E1^E4 proteins was compared. (D) Extracts from cells expressing wild-type 16E1^E4 (in the absence and presence
of roscovitine) or S32A-16E1^E4 (only in the absence of roscovitine) were separated using 2D gel electrophoresis, in the first dimension by iso-electric focusing and in
the second dimension by SDS-PAGE.
240 C.E. Davy et al. / Virology 349 (2006) 230–244the regions where previously events within the life-cycle have
been found to occur. Cells within the lesion contain varying
amounts and distributions of cyclin A. Those in the basal and
parabasal layers have predominantly nuclear cyclin A. In
comparison, cells in the upper layers of the epithelium thatFig. 8. Association of 16E1^E4 with cyclin A in lesions induced by HPV16. (A) An
and cyclin A (red). A DAPI nuclear stain was included (blue). The regions where ev
Scale bar equals 20 μm. (B) The cells highlighted by arrows in panel A are shownexpress 16E1^E4 have some cytoplasmic cyclin A. Further
magnification of these cells is shown in Fig. 8B, and cyclin A
can be seen to localize closely with the sites of 16E1^E4
accumulation, suggesting that the phenomena we have observed
in cell culture may also occur in vivo.HPV-16-induced lesion was double stained for the presence of 16E1^E4 (green)
ents in the life-cycle are expected to occur are shown on the right of the figure.
enlarged. Scale bar equals 10 μm.
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It is shown here that the HPV16 E1^E4 protein is able to bind
to cyclin A complexes and hold them in the cytoplasm. It is also
shown that 16E1^E4 is a substrate for the Cdk2/cyclin A kinase
complex, and that at least in cell culture, the residue targeted by
Cdk2/cyclin A in vitro is phosphorylated in vivo.
Cyclin A is believed to be a key cell cycle regulator that
binds both Cdk1 and Cdk2 and has roles in both S phase and in
the G2/M transition, although its precise functions are not fully
understood. The activity of cyclin A-dependent kinases during
S phase and the localization of cyclin A to sites of DNA
replication (Sobczak-Thepot et al., 1993) implicate cyclin A in
the control of cellular DNA replication. This is supported by
experiments in which either cyclin A anti-sense constructs or
anti-cyclin A antibodies were able to inhibit entry into S phase
(Girard et al., 1991; Zindy et al., 1992). Further experiments
have shown cyclin A to have at least two functions during S
phase, the first in activating DNA replication complexes
preassembled on the chromatin and the second in preventing
re-replication by inhibiting the assembly of new replication
complexes (Coverley et al., 2002). However, whether cyclin A
is absolutely required for all cell cycles is not clear as it has
been observed that cyclin A null mouse embryonic cells are
able to both replicate their DNA and divide (Winston et al.,
2000), and the situation may actually involve a certain degree
of functional redundancy between the different cyclin types.
While we cannot rule out completely that 16E1^E4 may have
some effect on the ability of cyclin A to perform its S phase
roles, it seems unlikely since at this stage of the cell cycle,
16E1^E4 is not observed to associate significantly with cyclin
A. Moreover, we observe no difference in the 4-h flow
cytometry profiles of 16E1^E4-expressing cells compared to
β-gal cells, providing further evidence that 16E1^E4 is not
acting on cyclin A during S phase.
In addition to its role in S phase, cyclin A also seems to be
involved in controlling the G2/M boundary because inhibition
of Cdk2/cyclin A activity in HeLa cells can prevent mitotic
entry (Furuno et al., 1999). This stage of the cell cycle is likely
to be more relevant for 16E1^E4-induced effects because it is
here and not in S phase that good association with Cdk2/cyclin
A is observed. Cdk2/cyclin A activity operates ahead of cyclin
B1 translocation to the nucleus, and it is thought that while the
Cdk1/cyclin B1 complex triggers nuclear membrane break-
down, it is Cdk2/cyclin A activity that induces chromosome
condensation (Furuno et al., 1999; Hagting et al., 1999). Our
previous work demonstrated that cells expressing 16E1^E4
failed to translocate cyclin B1 into the nucleus and did not enter
mitosis (Davy et al., 2005). However, it was not clear why
condensation of the chromosomes did not occur since this event
does not require cyclin B1. From the work presented here, it
appears that the association of 16E1^E4 with cyclin A may
prevent chromosome condensation, and it may be that by
targeting both A and B cyclins, 16E1^E4 is able to more
efficiently block cell cycle progression. Targeting more than
one cyclin may be necessary in light of the functional
redundancy of cyclins. While the data shown here do notsupport the idea that 16E1^E4 also interacts with other Cdk/
cyclins, e.g., cyclin E, D, Cdk4, neither do the data rule this out.
It may be that 16E1^E4 is indeed also able to interact with these
proteins but not at the points in the cell cycle which were
investigated here, i.e., 4 and 16 h post-release of an aphidicolin
block. Further work will be required to determine if this is
indeed the case.
One protein that is thought to be phosphorylated by Cdk2
kinase complexes is the HPV E1 protein (Ma et al., 1999).
Phosphorylation of E1 on Cdk phosphorylation sites results in
its accumulation in the nucleus (Deng et al., 2004), and
prevention of phosphorylation results in down-regulation of
E2/ori-dependent replication (Ma et al., 1999). It may be that
by altering the intracellular distribution of Cdk/cyclin com-
plexes, E1^E4 may be able to alter phosphorylation of E1 and
hence viral DNA replication. Given the dependence of viral
DNA amplification on the presence of E1^E4 (Peh et al.,
2004; Wilson et al., 2005), it will be interesting to see whether
our T22A,T23A mutation affects genome amplification.
Although not themselves cyclin A-dependent kinase targets,
the E7 proteins from HPV types 6, 16, and 31 are able to
associate with and increase the activity of Cdk2/cyclin A (He
et al., 2003). The presence of 16E1^E4 may be able to
modulate this effect. Interestingly, it has been shown that the
abnormal centrosome duplication that is induced by HPV16
E7 is critically dependent on cyclin/Cdk2 activity (Duensing et
al., 2004).
The difference in ability of 16E1^E4 to associate with
cyclin A at 4 h and 16 h post-block release is dramatic. How is
it that 16E1^E4, a cytoplasmic protein, is able to sequester in
the cytoplasm, cyclin A, a protein that until a few hours
previous had appeared predominantly nuclear? The answer
perhaps lies in the shuttling activity of cyclin A which
although normally appearing nuclear is actually translocating
between the nucleus and the cytoplasm with its import vastly
exceeding its export (Jackman et al., 2002). Thus, progressive
interaction of cyclin A with 16E1^E4 as the former passes
transiently through the cytoplasm could eventually lead to
depletion of cyclin A from the nucleus. Other potential
reasons why association occurs at 16 h but not at 4 h include
differences in the levels or modification of proteins. Our data
suggest that differences in the levels of 16E1^E4, cyclin A,
Cdk1, and Cdk2 are not responsible for the cell-cycle
specificity, but they do not rule out differences in levels of
some other as yet unknown factor required for interaction.
Similarly although the modification of 16E1^E4 that results in
its slower migration on SDS-PAGE does not seem to facilitate
association with cyclin A, there may be other modifications of
16E1^E4, cyclin A, or another factor that facilitate association
at 16 but not 4 h. Whatever the event is in G2 that promotes
association, it may be related to the re-organization of the
16E1^E4 networks since this too appears to be a phenomenon
primarily found in G2.
Cytoplasmic accumulation of cyclin A has previously
been observed in response to UV irradiation (Hiromura et al.,
2002). Under these conditions, the level of active Cdk2/
cyclin A complexes in the cytoplasm builds up and acts
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already known to promote apoptosis (Raj et al., 2004), and it
may be that its ability to hold cyclin A in the cytoplasm
contributes to this.
The interaction of 16E1^E4 with active Cdk/cyclin A
complexes appears to result in phosphorylation of serine 32 of
16E1^E4. It has already been observed, at least in lesions
caused by HPV1 and 11, that in vivo phosphorylation of the
E1^E4 protein can occur (Bryan et al., 2000; Grand et al.,
1989). Although it is not clear what kinases are responsible,
phosphorylation is thought to alter the intracellular distribution
and multimerization abilities of 11E1^E4. It will be interesting
to determine what, if any, effect serine 32 phosphorylation has
on the activity of the 16E1^E4 protein.
Given the significance of cyclins for cell cycle progression
and the ability of 16E1^E4 to bind at least two members of this
protein family, it will be important to investigate the effect of
abrogating this interaction in the HPV16 organotypic raft
culture system.
Materials and methods
Cell culture, transfection, and recombinant adenovirus (rAd)
infection
SiHa cells were synchronized and infected with rAd as
previously described (Davy et al., 2002). Briefly, cells were
synchronized at the G1/S border by 48-h incubation in low
serum and then aphidicolin for 22 h. Cells were infected with
recombinant adenovirus (rAd.β-gal expressing β-galactosidase
or rAd.16E1^E4-expressing wild-type 16E1^E4) at a multi-
plicity of infection of 100, for 6 h beginning 22 h prior to
harvest. Four or sixteen hours prior to harvest, the cells were
released from the aphidicolin block.
pMV11.16E1^E4 was mutated to pMV11.S32A-16E1^E4
using Quikchange Site Directed Mutagenesis (Stratagene). This
plasmid and plasmids that express β-gal (pCDNA6.β-gal),
wild-type 16E1^E4 (pMV11.16E1^E4), T22A,T23A-16E1^E4
(pMV11. T22A,T23A 16E1^E4), and wild-type 11E1^E4
(pMV11.11E1^E4) were transfected into SiHa cells as previ-
ously described (Davy et al., 2002). Briefly, DNAwas prepared
using the EndoFree Plasmid Maxi Kit (QIAgen) and transfected
into cells using Effectene (QIAgen). The cells were harvested at
24 h post-transfection for 2-D SDS-PAGE analysis and at 48 h
post-transfection for immunostaining. Roscovitine (30 μM;
Calbiochem) was added to some cells for 16 h prior to harvest.
Fractionation
To fractionate the cells for Western blotting, pellets of
5 × 105 cells were resuspended in 400 μl of NP-40 fractionation
buffer (0.5% NP-40, 10 mM EDTA, 50 Uml−1 benzonase
[VWR] and protease inhibitor cocktail [Roche] in phosphate
buffered saline [PBS]). The cells were lysed in this buffer by
pipetting up and down and then were immediately centrifuged
at 10,000 × g for 5 min at 4 °C. The supernatant was harvested
to obtain the NP-40-soluble fraction. The NP-40-insolublepellet was resuspended in 400 μl of 1% SDS, 5 mM
dithiothreitol (DTT) and incubated for 10 min at 95 °C. The
extracts were centrifuged at 10,000 × g for 5 min at room
temperature. The supernatant was harvested to obtain the NP-
40-insoluble (SDS-soluble) fraction. Equal volumes of NP-40-
soluble and insoluble fractions were loaded for Western
blotting.
GST pull-downs
Vectors based on pGEX that express glutathione S
transferase (GST), wild-type 16E1^E4 fused to GST (GST-
16E1^E4) and T22A,T23A16E1^E4 fused to GST (GST-T22A,
T23A16E1^E4) have been previously described (Davy et al.,
2005; Doorbar et al., 1992). Expression and purification of
GST, GST-16E1^E4, and GST-T22A,T23A16E1^E4 proteins
were essentially as previously described (Keen et al., 1994). The
integrity of the proteins bound to beads was confirmed by
Coomassie stain of SDS-polyacrylamide gels. These gels were
used to determine the volumes of beads having equivalent levels
of protein coupling. Unsynchronized SiHa cells were harvested
and lysed in 0.5% NP-40, 50 Uml−1 benzonase, protease
inhibitor cocktail (Roche); PBS. The lysate was centrifuged at
13 krpm for 5 min at 4 °C, and the supernatant was diluted 1:10
in pull-down buffer (0.05% NP-40, 10 μgml−1 BSA, protease
inhibitor cocktail; PBS). Diluted supernatant (1 ml) was added
to each of 5 μl of GST beads plus 45 μl of uncoupled beads,
50 μl of GST-16E1^E4 beads, or 50 μl of GST-T22A,
T23A16E1^E4 beads. Control tubes were set up containing
beads and buffer alone. The mixtures were rotated at 4 °C for
1 h and washed four times with pull-down buffer. Proteins were
eluted from the beads by boiling for 5 min at 95 °C in 30 μl
1 mM DTT, 10% SDS.
Kinase assays, mass spectrometry, 1D and 2D electrophoresis
and Western blotting
For in vitro kinase reactions, bacterially expressed wild-type
16E1^E4 or S32A-16E1^E4 both fused at the C-terminus to 6
histidine residues were used. Purified 16E1^E4 proteins (1 μM)
were incubated with 50 U Cdk2/cyclin A (NEB) in 1× reaction
buffer (NEB) containing 1 mM ATP/γ-32P-ATP (250 μCi/
μmol) at 30 °C for 30 min, in a total volume of 25 μl. The
reactions were stopped by addition of 12.5 μl of 3× SDS sample
buffer plus DTT (NEB). Samples were separated on 15% SDS-
polyacrylamide gels. Phosphorylation was analyzed using a
Storm Phosphorimager and ImageQuant software (Molecular
Dynamics).
In vitro phosphorylated wild-type 16E1^E4 fused at the C-
terminus to 6 histidine residues was purified, digested with
chymotrypsin, and analyzed by mass spectrometry. Using
MALDI-mass spectrometry an ion of mass to charge ratio 2082
was observed, corresponding to mono-phosphorylated peptide
of residues 17–34. Nanospray mass spectrometry coupled with
collision-induced fragmentation of peptide ion 17–34 produced
an ion of mass to charge ratio 469.15 corresponding to the
mono-phosphorylated peptide of residues 32–34.
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by lysing in 2% SDS, 1 μg/ml okadaic acid and benzonase.
Cell extract (10 μl) plus 90 μl of buffer containing 5 M urea,
2 M thiourea, 2% CHAPS, 2% SB 3–10, 65 mM DTT,
20 mM Tris pH 9.5, and 0.1 mM EDTA were centrifuged at
100,000 × g for 50 min at 16 °C. The supernatant plus 0.8 μl
of IPG buffer (GE Healthcare) was filtered through a 0.22 μM
membrane before loading onto a pH 6–11 IPG strip (GE
Healthcare). Iso-electric focusing was performed using the
Multiphor II system (GE Healthcare), a MultiTempII thermo-
static circulator set to 20 °C and an EPS 3501 Xlpower supply
for 60,000 Vh. The IPG strip was equilibrated in equilibration
buffer (50 mM Tris–HCl pH 8.8, 6 M urea, 30% glycerol, 2%
SDS) containing 2% DTT for 15 min, followed by
equilibration buffer containing 2.5% iodoacetamide and a
trace of bromophenol blue for another 15 min. SDS-PAGE
was performed by electrophoresing from the equilibrated strip
into a 15% polyacrylamide gel.
For Western blotting, samples were separated by SDS-PAGE
and transferred to an Immobilon P membrane (Millipore).
Detectionwaswith anti-16E1^E4 clone TVG402 (Doorbar et al.,
1992), anti-cyclin A clone 6E6 (Novocastra), anti-cyclin B1
clone V152 (Neomarkers), anti-cyclin D clone 5D4 (Upstate),
anti-cyclin E (Upstate), anti-Cdk1Ab3 (Neomarkers), anti-Cdk2
clone 748 (Santa Cruz), anti-Cdk4 clone 749 (Santa Cruz), anti-
tubulin cloneB512 (Sigma), anti-histone 2B clone 371 (Upstate),
or anti-GAPDH clone 374 (Chemicon) then anti-rabbit
(NA9340) or anti-mouse (NA931) HRP conjugates (Amersham
Pharmacia Biotech), followed by detection using the ECL kit
(Amersham Pharmacia Biotech).
Immunostaining and flow cytometry
For microscopy, monolayer cells were fixed for 5 min in 5%
formaldehyde in PBS and permeabilized in 0.5% Triton X-100
in PBS for 10 min. Sections were fixed in 10% formaldehyde
and permeabilized using a microwave/citric acid based method
(Southern et al., 2000). Nuclei were stained with 1 μgml−1
DAPI (4′-6-diamidino-2-phenylindole; Sigma). 16E1^E4 was
detected using TGV405 (Doorbar et al., 1997) directly
conjugated to Alexa-488 (Molecular Probes). Other antigens
were detected with anti-11E1^E4 (Peh et al., 2002), anti-Cdk1
clone Ab-1 (Oncogene), anti-β-gal polyclonal 55976 (ICN
biomedicals), anti-tubulin clone B512 (Sigma), anti-cyclin A
clone 6E6 (Novocastra), and anti-cyclin B1 clone GNS1
(Neomarkers). Primary antibodies were detected using Alexa-
488- or Alexa-594-conjugated anti-mouse or anti-rabbit anti-
bodies (Molecular Probes). The cells were examined using a
fluorescent Labophot II monochrome camera (Nikon) and IP
Lab imaging software (Roper Scientific). Confocal images were
obtained using a TCS-SP1 DMRXE confocal microscope
(Leica) and LCS imaging software (Leica).
Flow cytometry was carried out as previously described
(Davy et al., 2002). Briefly, cells were stained as for microscopy
and then with propidium iodide (12.5 μgml−1). Their DNA
content was analyzed using a FACSCalibur and CellQuest
software (Becton Dickinson).Acknowledgments
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